You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
基石藥業(02616.HK)將向公司主席江寧軍發行911萬股新股
格隆匯 05-21 22:29

格隆匯5月21日丨基石藥業(02616.HK)公告,根據首次公開發售後受限制股份獎勵計劃,1012萬份受限制股份單位已於2019年8月15日向公司主席、執行董事兼首席執行官江寧軍博士授出。為於當前市況下為公司提供靈活性,公司已修訂其受限制股份單位承授人的相關授予函,規定授予承授人(包括江博士及其他獨立第三方承授人)的受限制股份單位可透過發行新股份來滿足。

為滿足向江博士授予受限制股份單位,將於受限制股份單位歸屬時向江博士配發及發行合共911萬股新股份。按於授出日期計算,假設除向江博士發行新股份外不會發行額外股份,新股份佔公司已發行股本總額約0.90%及公司經擴大已發行股本約0.88%。按於本公告日期計算,新股份佔公司現有已發行股本總額約0.88%及公司經發行新股份擴大後已發行股本總額約0.88%。

按授出日期的每股收市價10.52港元及本公告日期的每股收市價7.76港元計算,新股份的市值分別約為9580萬港元及7070萬港元。

此外,浤博資本已獲委任為獨立財務顧問,以就配發及發行新股份向獨立董事委員會及獨立股東提供意見。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account